Yisheng Biopharma is an international, fully integrated bio-pharmaceutical corporation. YishengBio is a globally, fully integrated biopharmaceutical firm based in the capital city of Beijing. The organization is involved in the exploration, advancement, and commercialization of groundbreaking biotherapeutics for cancer and infectious diseases through innovative PIKA® immunomodulating technology. YishengBio has operations in the United States, China, and Singapore, boasting a workforce of over 500 individuals.